A major ethical and medical controversy has emerged as Danish researchers received approval to proceed with a trial that will delay hepatitis B vaccinations for thousands of African newborns. The study, which aligns with the vaccine skepticism of a key U.S. health official, has sparked debate over whether withholding a proven preventive measure is justified in the name of research. Critics argue the trial raises serious questions about equitable access to life-saving medical interventions, particularly in vulnerable populations. The decision comes amid ongoing tensions between public health policies and growing skepticism toward vaccination programs.
Recommended dose of hepatitis B vaccine will be withheld from thousands of newborns by Danish researchersA controversial research trial that will withhold hepatitis B vaccines from some African newborns was given approval to move forward this week.It is a central part of the vaccine vision for Robert F Kennedy Jr, the secretary of the US Department of Health and Human Services (HHS) and a longtime vaccine opponent. Continue reading...
